Skip to content

Medgex

Active Private limited companyfounded 2022active for 4 yearsPaul Hymanslaan 1, 1200 Woluwe-Saint-LambertKBO/BCE: BE 0793.602.332

Lifetime

4 annual accounts with figures on one time axis
peak of €80,152 in 2023
€74,341▲ 85.4%
peak of €53,234 in 2023
€24,555▲ 48.0%
peak of €79,997 in 2024
€79,997unchanged
€328,390▲ 467%
Board1 name since 2022
1 director
Documentsfilings and deeds
21-08-202621 days late
2025micro format
Gross margin from €40,093 to €74,341Result from €16,593 to €24,555Dividend €24,555Debts from €57,870 to €328,390Investments €225,374Cash from €82,938 to €56,926

Key points

from the 2025 annual accounts

Equity

€79,997 =
79,9972024+24,555Profit-24,555Dividend79,9972025

Medgex paid out €24,555 in dividends. That is 100% of the 2025 profit.

Turnover

≈ €170,000 estimated

The micro format states no turnover.

Debts

€328,390 ▲ 467%
Financial debts
+179,470
Suppliers
+64,232
Other debts
+29,900
The rest
-3,082

Debts rose by €270,521 in 2025. A dividend stands under other debts on the balance sheet date until it is paid.

Investments

€225,374 5.9 times depreciation
2022202320242025

Green is investment, beige is depreciation.

Filings

4 annual accounts 2 late
AprilJune31 JulyOctober2022202320242025

The 2022 accounts came in latest, 28 days after the end of the period.

Position in the sector

19.6%

Lower solvency than 80% of companies in human health. Sector median 63.1% · 21,368 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 7,984 companies had the same profile as Medgex has now. Each dot stands for 20 companies, two years later.

94.2%
were still trading
1.9%
stopped another way
3.6%
went bankrupt
  • Micro
  • 2 to 5 years old
  • solvency 10 to 30%
  • a profit of 5% of the balance sheet or more

Another 0.3% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,965 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 7,984 companies, not a prediction for Medgex. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 14-11-2022
  • founderdeed of 17-11-2022
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0793602332
Incorporation Founding capital of €6,000, 100 shares · Founded by · appointed as director · published on 17-11-2022 · Gazette deed
First establishment Paul Hymanslaan 1, Woluwe-Saint-Lambert
All 9 events

Comparable companies

same main activity, similar in size and age
Company
Medgex Woluwe-Saint-Lambert €408,387 €74,341 19.6% -
Dr. Vandendorpe Ann-Sophie - Huisarts Erpe-Mere €418,770 €68,705 9.4% -
Docteur Simon Quentin Ath €401,710 €78,922 29.1% -
Dr. Annaïk Van Branteghem, huisarts Ghent €381,205 €75,787 1.3% -
Docteur Julie Collard Dinant €338,749 €71,739 27.1% -
Huisarts Jan Vanroose Zwevegem €483,556 €79,955 17.0% -
Dr. Linders Antwerp €425,837 €85,523 15.1% -

These companies have the same main activity as Medgex: general medical practice (NACE 86210). They are comparable in size and age: total assets between €339,000 and €484,000, founded between 2022 and 2023.

Official details

Source: KBO
Status
Active since 15-11-2022Normal situation
Activity
General medical practiceNACE 86210and 1 other
Establishment unit
2.347.490.8621200 Woluwe-Saint-Lambert, since 15-11-2022
Financial year end
31 December
Peppol
Reachable since 08-12-2025
Company details

Annual accounts 2025

€408,387▲ 196%
Filing
Filed on 21-08-2026
Financials

Insights on Medgex

Medgex files the micro format. That format states no turnover. The gross margin rose from €6,569 in 2022 to €74,341 in 2025.

The balance sheet grew most in 2025 through fixed assets, financed with long-term debt.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Medgex

What is the company number of Medgex?
The company number of Medgex is 0793.602.332. The VAT number is the same number with BE in front: BE 0793.602.332.
Where is Medgex based?
The registered office is at Paul Hymanslaan 1, 1200 Woluwe-Saint-Lambert.Company details
What does Medgex do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of Medgex?
Medgex is a private limited company (BV).
When was Medgex founded?
Medgex was founded on 15-11-2022.
Is Medgex still active?
Yes, Medgex is an active enterprise in the KBO register.
What is the turnover of Medgex?
The turnover in financial year 2025 is ≈ €170,000. This figure is estimated from the gross margin of €74,341 and 33 comparable companies (NACE 862). It probably lies between €130,000 and €210,000.Financials
Is Medgex profitable?
In financial year 2025, Medgex made a profit of €24,555.
Where can I find the annual accounts of Medgex?
Medgex filed 4 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Medgex due?
Medgex must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.